[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"notifications-list":3,"$fou0h0wprmo8u":5},{"data":4},[],{"data":6,"error":10},{"id":7,"documentId":8,"slug":9,"name":9,"proprietary_name":10,"non_proprietary_name":10,"is_proprietary":10,"active_ingredient":10,"administration_route":10,"available_strength":10,"dosage_form":10,"dose_schedule":10,"drug_unit":10,"is_available_generically":10,"mechanism_of_action":10,"overdosage":10,"warning":10,"species":11,"citations":12,"dose_schedules":27,"available_strengths":34,"label_statements":39,"drug_classes":44,"specialties":50,"medical_conditions":51,"animal_species":52},1665,"u8xy8lt03fzjg5e91jpgk66u","ciclesonide",null,[],[13,19,23],{"source":14,"licence":15,"source_url":16,"harvested_by":17,"retrieved_at":18},"EMA centrally authorised medicines","EMA reuse with attribution","https:\u002F\u002Fwww.ema.europa.eu\u002Fen\u002Fdocuments\u002Freport\u002Fmedicines-output-medicines-report_en.xlsx","load-reference-corpus.cjs","2026-09-07",{"source":20,"licence":21,"source_url":22,"harvested_by":17,"retrieved_at":18},"FDA Green Book","US public domain","https:\u002F\u002Fanimaldrugsatfda.fda.gov\u002Fadafda\u002Fapp\u002Fsearch\u002Fpublic\u002FingredientsInformationExcel\u002FSection2ActiveIngredients",{"source":24,"licence":25,"source_url":26,"harvested_by":17,"retrieved_at":18},"UK VMD PID","OGL v3.0","https:\u002F\u002Fwww.vmd.defra.gov.uk\u002Fproductinformationdatabase\u002Fdownloads\u002Fvmd_productinformationdatabase.xlsx",[28],{"id":29,"dose_text":30,"species":31,"administration_route":32,"limitation":10,"source_label":33},11712,"The initial dose is 8 actuations (2744 mcg ciclesonide) twice daily for 5 days, followed by 12 actuations (4116 mcg ciclesonide) once daily for 5 days.","Horses","Intranasal inhalation","Aservo® EquiHaler®",[35],{"id":36,"strength_text":37,"dosage_form":38,"proprietary_name":33,"species":31,"source_label":33},10185,"343 mcg ciclesonide\u002Factuation","Inhalation spray",[40],{"id":41,"kind":42,"statement":43,"species":31,"limitation":10,"source_label":33},16906,"indication","For the management of clinical signs associated with severe equine asthma in horses.",[45],{"id":46,"documentId":47,"slug":48,"name":49},822,"w6ha1c9jm6bdr9mrj7mg5l95","glucocorticoid-receptor-agonists","Glucocorticoid Receptor Agonists",[],[],[]]